Learn more about Sadiqa Mahmood

Author Bio

Sadiqa Mahmood

Sadiqa Mahmood is the Senior Vice President and General Manager of the Life Sciences business at Health Catalyst and contributes to the overall vision and growth for the company. Sadiqa’s work focuses on identifying and addressing areas of high unmet need for therapeutic development through application of real-world data. She is an advisor to several healthcare organizations and global policy makers. Sadiqa is a dental surgeon and holds a master’s degree in public health from the Harvard School of Public Health. Passionate about improving access to care and patient outcomes by leveraging data and healthcare ecosystem, Sadiqa has spent her career at the intersection of medicine, policy, technology, and analytics. Previously she led clinical analytics, quality and safety, value-based contracting, and population health across healthcare organizations, including the Dana-Farber Cancer Institute, Partners HealthCare System, and Boston Medical Center. Sadiqa has been an advocate of collaborative learning system in healthcare and has steered cross-industry multi-stakeholder national and global collaborations to drive healthcare innovation. She joined Health Catalyst in 2019 as SVP of Medical Affairs. Sadiqa has lived and worked in Asia and UK in addition to the US. She is based in Boston, Massachusetts. Outside of work, she is a Formula 1 fan and race as a member of a local team.

Read articles by Sadiqa Mahmood

Insights

Alyssa Antonopoulos
Adem Albayrak
Sadiqa Mahmood
Elia Stupka, PhD

Data-Driven Precision Medicine: A Must-Have for the Next-Generation of Personalized Care

Under a precision medicine approach, clinicians, academics, and pharma and biotech researchers and regulators aim to deliver the right drug for the right patient at the right time. Data, however, can present a challenge to precision medicine goals due to gaps in clinical care, research, and drug development when organizations don’t have the ability to capture and report on relevant real-world data. With the right systems to collect and share clinical and molecular data, the healthcare industry can realize the full benefits of precision medicine.